The purpose of this study is to evaluate the Cimicifuga racemosa effects on the sexuality of women with Breast cancer using tamoxifen or aromatase inhibitor through questionnaires.
For the study will be recruited 60 women treated with breast cancer, using tamoxifen or aromatase inhibitor, are in menopause, hot flashes and has with or without sexual life. They will answer the questionnaires: Kupperman, World Health Organization Quality of Life (WHOQOL) and those sexually active will have Female Sexual Function Index (FSFI). The control group will have 30 patients using tamoxifen alone or inhibitor. The other group will have 30 patients receiving tamoxifen or inhibitor and will start with 2 tablets per day of dry extract of Cimicifuga racemosa. They will be followed for 6 months and answer questionnaires at the first visit, 3-month and 6-month follow-up.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
60
WHO defines Quality of Life as individuals perception of their position in life in the context of the culture and value systems in which they live and in relation to their goals, expectations, standards and concerns.
FSFI questionnaire application for evaluation of sexual function at the first visit, 3-month and 6-month follow-up.
Kupperman scale is a tool to help evaluate the severity of menopausal symptoms
Carolina Furtado Macruz
São Paulo, São Paulo, Brazil
RECRUITINGHot flashes (score of hot flashes)
Determine the score of hot flashes
Time frame: 6 months
Sexual function (score of sexual function questionnaire (FSFI)
Determine the score of sexual function questionnaire (FSFI)
Time frame: 3 months
Sexual function (score of sexual function questionnaire (FSFI)
Determine the score of sexual function questionnaire (FSFI)
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
The Cimicifuga racemosa effects on the sexuality of women with Breast cancer
The Cimicifuga racemosa effects on the sexuality of women with Breast cancer using tamoxifen
The Cimicifuga racemosa effects on the sexuality of women with Breast cancer using aromatase inhibitor.